Wed, Sep 3, 2014, 2:07 AM EDT - U.S. Markets open in 7 hrs 23 mins

Recent

% | $
Quotes you view appear here for quick access.

Allergan Inc. Message Board

  • lebuitre lebuitre May 2, 2012 12:28 PM Flag

    Excellent Buying Opportunity

    Excellent CC!
    After a real good quarter, AGN stock presents an excellent entry point, or buying opportunity when this great stock seems to go on sale following every quarterly earnings report.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Sientra is a Brazilian Implant company that is run by a past CEO of Allergan. He has pledged to sell breast implants only to board certified and board eligible plastic surgeons. Many large plastic surgery accounts were very happy with this news and pledged to move their purchases to Sientra. This will likely lead to hit for Allergan's and Mentor's Implant sales.

      • 1 Reply to savannah5361
      • "Sientra is a Brazilian Implant company that is run by a past CEO of Allergan." - savannah536..
        OOPS, that is a major prevarication -- please double check your facts.
        Mssr. Hani Zeini was never CEO of Allergan(AGN). His "c-vitae" shows that prior to founding Sientra, he served as EVP at Inamed Corp. under Inamed-CEO, Nick Teti.
        It's great to have the extra competition in mammary implant market, however; Allergan and Mentor-JNJ are the established global market leaders representing the gold std.
        Reputation and experience will rule in the mammary implant market sector.
        Please let me direct your attention to the PIP implants scandal that's dominating the global mammary implant market.
        I am betting that Allergan will emerge the winner, and the major beneficiary when the dust is cleared, heck; AGN is already winning in the replacement of the PIP implants in Europe.

 
AGN
166.45+2.77(+1.69%)Sep 2 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.